Data from hospitals on medication use are valuable for assessing clinical practice, including undesirable variation, work on therapeutic guidelines and hospital economics. Figures on the use of ...

Schizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as second-generation or "atypical" antipsychotics ...

And China has not detected any significant fentanyl abuse, the report said. However, it warned that drug users have turned to more accessible, cheaper and similarly effective addictive substances such ...

The 2025 List of Prohibited Substances and Methods (List) went into effect on 1 January 2025. The List and the Q&A s can also be consulted under the Athlete and Support Personnel section. A Summary of ...

Introduction Major depressive disorder (MDD) is a major global healthcare challenge. This is, in part, due to the lack of treatment response and chronic course of MDD. Such a course of illness is ...

A treatment history is a fundamental part of the healthcare consultation. Current drugs (prescribed, over the counter, herbal remedies, drugs of misuse) and how they are taken (frequency, timing, ...

Objective To determine what components of a checklist contribute to effective detection of medication errors at the bedside. Design High-fidelity simulation study of outpatient chemotherapy ...

Depression affects 1%-2% of children younger than 13 in the U.S. and can arise as early as age 3, but a specialized ...

L: On June 6 th, AARP sent a letter to Representative Taylor (R-OH) and Representative Schakowsky (D-IL) expressing support for the Drug-Price Transparency for Consumers (DTC) Act of 2025 (H.R. 3789).